Evidence map›Paper›PMID 37119440›Full record

ReviewSmall (Weinheim an der Bergstrasse, Germany)2023

An Overview of Nanoparticle Protein Corona Literature.

Mohammad J Hajipour, Reihaneh Safavi-Sohi, Shahriar Sharifi, Nouf Mahmoud, Ali Akbar Ashkarran, Elizabeth Voke, Vahid Serpooshan, Milad Ramezankhani, Abbas S Milani, Markita P Landry and 1 more

Abstract readReview
In one paragraph

Review in Small (Weinheim an der Bergstrasse, Germany), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 65 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
65citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

65 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Review
  5. Article
  6. Review
  7. Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Review
  18. Review
  19. Review
  20. Microorganisms · 2026
    Article

5 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Mohammad J HajipourDepartment of Radiology and Precision Health Program, Michigan State University, East Lansing, MI, 48824, USA.
Reihaneh Safavi-SohiDepartment of Radiology and Precision Health Program, Michigan State University, East Lansing, MI, 48824, USA.
Shahriar SharifiDepartment of Radiology and Precision Health Program, Michigan State University, East Lansing, MI, 48824, USA.
Nouf MahmoudDepartment of Radiology and Precision Health Program, Michigan State University, East Lansing, MI, 48824, USA.
Ali Akbar AshkarranDepartment of Radiology and Precision Health Program, Michigan State University, East Lansing, MI, 48824, USA.
Elizabeth VokeDepartment of Chemical and Biomolecular Engineering, University of California, Berkeley, CA, 94720, USA.
Vahid SerpooshanWallace H. Coulter Department of Biomedical Engineering, Emory University School of Medicine and Georgia Institute of Technology, Atlanta, GA, 30322, USA.
Milad RamezankhaniSchool of Engineering, University of British Columbia, Kelowna, BC, V1V 1V7, Canada.
Abbas S MilaniSchool of Engineering, University of British Columbia, Kelowna, BC, V1V 1V7, Canada.
Markita P LandryDepartment of Chemical and Biomolecular Engineering, University of California, Berkeley, CA, 94720, USA.ORCID 0000-0002-5832-8522
Morteza MahmoudiDepartment of Radiology and Precision Health Program, Michigan State University, East Lansing, MI, 48824, USA.ORCID 0000-0002-2575-9684

Funding

A Nanostructured Skin Patch to Heal Chronic WoundsR01DK131417 · NIDDK · MICHIGAN STATE UNIVERSITY · PI Morteza Mahmoudi · 2022 to 2026
$2.0M
NIDDK NIH HHS R01 DK131417
6 · The paper itself

Abstract

The protein corona forms spontaneously on nanoparticle surfaces when nanomaterials are introduced into any biological system/fluid. Reliable characterization of the protein corona is, therefore, a vital step in the development of safe and efficient diagnostic and therapeutic nanomedicine products. 2134 published manuscripts on the protein corona are reviewed and a down-selection of 470 papers spanning 2000-2021, comprising 1702 nanoparticle (NP) systems is analyzed. This analysis reveals: i) most corona studies have been conducted on metal and metal oxide nanoparticles; ii) despite their overwhelming presence in clinical practice, lipid-based NPs are underrepresented in protein corona research, iii) studies use new methods to improve reliability and reproducibility in protein corona research; iv) studies use more specific protein sources toward personalized medicine; and v) careful characterization of nanoparticles after corona formation is imperative to minimize the role of aggregation and protein contamination on corona outcomes. As nanoparticles used in biomedicine become increasingly prevalent and biochemically complex, the field of protein corona research will need to focus on developing analytical approaches and characterization techniques appropriate for each unique nanoparticle formulation. Achieving such characterization of the nano-bio interface of nanobiotechnologies will enable more seamless development and safe implementation of nanoparticles in medicine.

Indexed as

Metal NanoparticlesNanoparticlesProtein CoronaNanomedicineProteinsReproducibility of ResultsProtein CoronaProteinsanalytical chemistrycharacterizationnanomedicineprotein coronareproducibilitystandard procedures

Identifiers

PMID37119440
PMCPMC10552659

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.